Mark Sabag
2017
Compensation breakdown
Option Awards | $533,375 |
---|---|
Salary | $604,637 |
Stock Awards | $1,066,630 |
Other | $317,108 |
Total | $2,521,750 |
Sabag received $1.1M in stock awards, accounting for 42% of the total pay in 2017.
Sabag also received $533.4K in option awards, $604.6K in salary and $317.1K in other compensation.
Rankings
In 2017, Mark Sabag's compensation ranked 4,383rd out of 14,666 executives tracked by ExecPay. In other words, Sabag earned more than 70.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,383 | 70th |
Manufacturing | 1,542 | 73rd |
Chemicals And Allied Products | 445 | 79th |
Drugs | 341 | 80th |
Pharmaceutical Preparations | 269 | 80th |
Sabag's colleagues
We found nine more compensation records of executives who worked with Mark Sabag at Teva Pharmaceutical Industries in 2017.
2017
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Yitzhak Peterburg
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Rob Koremans
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Carlo de Notaristefani
Teva Pharmaceutical Industries
Executive Vice President, Global Operations
2017
Michael Hayden
Teva Pharmaceutical Industries
Chief Scientific Officer
2017
Eyal Desheh
Teva Pharmaceutical Industries
Chief Financial Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Erez Vigodman
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Michael McClellan
Teva Pharmaceutical Industries